iPTH
OtheriPTH assay six hours after surgery
NCT Number: NCT02853721
150 patients divided into two groups.The experimental group was submitted at the assay of iPTH six hours after surgery whilst the control group was submitted to a daily assay of serum calcium and phosphorus.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Purpose: The aim of this randomized controlled trial was to validate the results of a previous prospective cohort study conducted in the same surgical unit regarding the use of concomitant intact parathyroid hormone (iPTH) and serum calcium measurement in predicting hypocalcemia after total thyroidectomy.
Methods: From January 2014 to January 2015, 150 patients underwent total thyroidectomy in our department and were divided into two groups. The experimental group was submitted at the assay of iPTH six hours after surgery whilst the control group was submitted to a daily assay of serum calcium and phosphorus. Sensitivity and specificity of different serum measurements have been calculated using the Receiver-operator characteristics (ROC) curve.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
iPTH assay six hours after surgery
Ca and P on postoperative day 1 and 2
Time frame: 1 month
Sensitivity and specificity of serum measurement using the Receiver-operator characteristics (ROC) curve
University of Cagliari
Other
Early Prediction of Hypocalcaemia Following Thyroid Surgery: A Prospective Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00743782
Autoimmune Diseases, Autoimmune Polyendocrine Syndrome Type 1
Bethesda, Maryland, United States
View Trial DetailsNCT06716632
Calcium Metabolism Disorders, Hypocalcemia
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05216419
Avitaminosis, Calcium Metabolism Disorders
Seoul, South Korea
View Trial DetailsNCT05260255
Autoimmune Diseases, Avitaminosis
Bangkok, Thailand
View Trial Details